These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6778187)

  • 21. Efficacy and safety of intravenous tocainide compared with intravenous lidocaine for acute ventricular arrhythmias immediately after cardiac surgery.
    Morganroth J; Panidis IP; Harley S; Johnson J; Smith E; MacVaugh H
    Am J Cardiol; 1984 Dec; 54(10):1253-8. PubMed ID: 6439023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
    Hellestrand KJ
    Eur Heart J; 1984 Sep; 5 Suppl B():87-94. PubMed ID: 6437822
    [No Abstract]   [Full Text] [Related]  

  • 23. Proarrhythmic effects of procainamide and tocainide in a canine infarction model.
    Steinberg JS; Sahar DI; Rosenbaum M; Cook JR; Bigger JT
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):52-9. PubMed ID: 1375688
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy and safety of oral tocainide and quinidine for benign and potentially lethal ventricular arrhythmias.
    Morganroth J; Oshrain C; Steele PP
    Am J Cardiol; 1985 Oct; 56(10):581-5. PubMed ID: 3931448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Randomized double-blind study of intravenous tocainide versus lidocaine for suppression of ventricular arrhythmias after cardiac surgery.
    Manolis AS; Smith E; Payne D; Rastegar H; Cleveland R; Estes NA
    Clin Cardiol; 1990 Mar; 13(3):177-81. PubMed ID: 2108835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of concurrent administration of metoprolol and tocainide in acute myocardial infarction.
    Renard MB; Bernard RM; Ewalenko MB; Englert M
    J Cardiovasc Pharmacol; 1983; 5(1):116-20. PubMed ID: 6186845
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The hemodynamic effects of intravenous tocainide in patients with heart disease.
    Winkle RA; Anderson JL; Peters F; Meffin PJ; Fowles RE; Harrison DC
    Circulation; 1978 Apr; 57(4):787-92. PubMed ID: 630689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic efficacy of combined intravenous and oral mexiletine in acute myocardial infarction. A double blind placebo-controlled study.
    Halinen MO; Pentikäinen PJ; Helin MJ; Rehnberg S
    Eur Heart J; 1984 Aug; 5(8):675-83. PubMed ID: 6383836
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.
    Winkle RA; Meffin PJ; Fitzgerald JW; Harrison DC
    Circulation; 1976 Dec; 54(6):885-9. PubMed ID: 791536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of a new oral agent (tocainide) in the acute treatment of refractory ventricular arrhythmias.
    Ryan W; Engler R; LeWinter M; Karliner JS
    Am J Cardiol; 1979 Feb; 43(2):285-91. PubMed ID: 760482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparative study of encainide and disopyramide in chronic ventricular arrhythmias: a double-blind placebo-controlled crossover study.
    Caron JF; Libersa CC; Kher AR; Kacet S; Wanszelbaum H; Dupuis BA; Poirier JM; Lekieffre JP
    J Am Coll Cardiol; 1985 Jun; 5(6):1457-63. PubMed ID: 2582017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of hypertensive patients with ventricular arrhythmias: comparison and combination of beta-blocker and anti-arrhythmic therapy.
    Di Somma S; Savonitto S; Petitto M; Liguori V; Magnotta C; de Divitiis O
    J Int Med Res; 1989; 17(2):113-24. PubMed ID: 2498141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Anti-arrhythmic effect of tocainide (lidocaine congener) on ventricular arrhythmias (author's transl)].
    Kuck KH; Hanrath P; Lubda J; Mathey D; Bleifeld W
    Dtsch Med Wochenschr; 1979 Nov; 104(48):1701-5. PubMed ID: 93043
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tocainide for drug-resistant sustained ventricular tachyarrhythmias.
    Adhar GC; Swerdlow CD; Lance BL; Clay D; Bardy GH; Greene HL
    J Am Coll Cardiol; 1988 Jan; 11(1):124-31. PubMed ID: 3121711
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Double-blind randomized comparison of intravenous tocainide versus lidocaine in the treatment of chronic ventricular arrhythmias.
    Mohiuddin SM; Hilleman DE; Mooss AN; Esterbrooks D; Sketch MH; Stengel LA; Butler ML
    Am Heart J; 1987 Aug; 114(2):296-302. PubMed ID: 3111238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral tocainide versus disopyramide: a double-blind, randomized, crossover study of outpatients with stable ventricular premature beats.
    McLaran CJ; Hossack KF; Neilson GH; Siskind V
    J Cardiovasc Pharmacol; 1984; 6(4):657-62. PubMed ID: 6206321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
    Echt DS; Liebson PR; Mitchell LB; Peters RW; Obias-Manno D; Barker AH; Arensberg D; Baker A; Friedman L; Greene HL
    N Engl J Med; 1991 Mar; 324(12):781-8. PubMed ID: 1900101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Placebo controlled study of prophylaxis of ventricular arrhythmias in acute myocardial infarction.
    Campbell RW
    Am Heart J; 1980 Dec; 100(6 Pt 2):995-9. PubMed ID: 7004159
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of xamoterol in acute myocardial infarction: blood pressure, heart rate, arrhythmias and early clinical course.
    McMurray J; Lang CC; MacLean D; Struthers AD; McDevitt DG
    Int J Cardiol; 1991 Jun; 31(3):295-303. PubMed ID: 1679047
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tocainide for refractory symptomatic ventricular arrhythmias.
    Podrid PJ; Lown B
    Am J Cardiol; 1982 Apr; 49(5):1279-86. PubMed ID: 6801955
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.